Edit Business Wire
17 Feb 2014
DUBLIN--(BUSINESS WIRE)--Research and Markets (http.//www.researchandmarkets.com/research/7r67r9/tinnitus) has announced the addition of the "Tinnitus - Pipeline Review, H2 2013" report to their offering. 'Tinnitus - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline ... It also reviews key players involved in the therapeutic development for Tinnitus. Scope ... Introduction ... gacyclidine - Drug Profile ... ....(size: 5.1Kb)
Edit PR Newswire
31 Oct 2013
31, 2013 /PRNewswire/ -- Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced that it has completed the acquisition of certain assets and rights to intellectual property (IP) related to the use of gacyclidine for the treatment of tinnitus from an affiliate of NeuroSystec Corporation....(size: 5.3Kb)
Edit PR Newswire
01 Feb 2012
 . , Feb. 1, 2012  /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Neuroprotection - Drugs, Markets and Companies. http.//www.reportlinker.com/p0203546/Neuroprotection---Drugs-Markets-and-Companies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication ... Forecasts are made until 2021 ... TABLE OF CONTENTS 0 ... 1 ... 2 ... Gacyclidine 81 ... 87 ... 88 ... Gacyclidine 221....(size: 100.5Kb)







×